RxDoctor Payments Data

James Altieri, MD

Family Medicine · Columbia, SCNPI 1720027477

Payments from drug & device makers

$5,351in general payments, 2019–2025

Across 310 payments — averaging $17.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$862
  • Lilly USA, LLC$629
  • AstraZeneca$621
  • AbbVie$529
  • Amgen$358
  • Pfizer$357
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$5,17797%
  • Education$1743%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,351 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$160,757
Medicare patients
456
Services billed
2,628

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide160$181,256
MounjaroTirzepatide136$154,517
TrulicityDulaglutide69$100,691
FarxigaDapagliflozin Propanediol116$98,159
JardianceEmpagliflozin75$79,055
XareltoRivaroxaban50$63,178
EliquisApixaban52$51,982
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog57$44,968
RybelsusSemaglutide26$39,137
RexultiBrexpiprazole16$35,360
LinzessLinaclotide33$30,043
OxycontinOxycodone Hcl23$29,578
MyrbetriqMirabegron32$27,146
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$22,405
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$19,697

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$629$255,208205 claims
Novo NordiskOzempic, Rybelsus$862$220,393186 claims
AstraZenecaFarxiga, Breztri Aerosphere$621$117,856141 claims
Boehringer IngelheimJardiance$105$79,05575 claims
Johnson & JohnsonXarelto, Invokana$32$76,31165 claims
PfizerEliquis$357$51,98252 claims
MerckJanumet Xr, Januvia$27$38,26151 claims
Otsuka America Pharmaceutical, Inc.Rexulti$74$35,36016 claims
AbbVieLinzess, Synthroid$529$33,24886 claims
Astellas Pharma US IncMyrbetriq$145$27,14632 claims
GSKTrelegy Ellipta$132$22,40520 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →